Correlation Between Monogram Orthopaedics and Pacific Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monogram Orthopaedics and Pacific Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monogram Orthopaedics and Pacific Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monogram Orthopaedics Common and Pacific Biosciences of, you can compare the effects of market volatilities on Monogram Orthopaedics and Pacific Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monogram Orthopaedics with a short position of Pacific Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monogram Orthopaedics and Pacific Biosciences.

Diversification Opportunities for Monogram Orthopaedics and Pacific Biosciences

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Monogram and Pacific is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Monogram Orthopaedics Common and Pacific Biosciences of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacific Biosciences and Monogram Orthopaedics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monogram Orthopaedics Common are associated (or correlated) with Pacific Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacific Biosciences has no effect on the direction of Monogram Orthopaedics i.e., Monogram Orthopaedics and Pacific Biosciences go up and down completely randomly.

Pair Corralation between Monogram Orthopaedics and Pacific Biosciences

Given the investment horizon of 90 days Monogram Orthopaedics is expected to generate 31.8 times less return on investment than Pacific Biosciences. But when comparing it to its historical volatility, Monogram Orthopaedics Common is 1.76 times less risky than Pacific Biosciences. It trades about 0.0 of its potential returns per unit of risk. Pacific Biosciences of is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  174.00  in Pacific Biosciences of on September 23, 2024 and sell it today you would earn a total of  23.00  from holding Pacific Biosciences of or generate 13.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Monogram Orthopaedics Common  vs.  Pacific Biosciences of

 Performance 
       Timeline  
Monogram Orthopaedics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Monogram Orthopaedics Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Monogram Orthopaedics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Pacific Biosciences 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pacific Biosciences of are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Pacific Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Monogram Orthopaedics and Pacific Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monogram Orthopaedics and Pacific Biosciences

The main advantage of trading using opposite Monogram Orthopaedics and Pacific Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monogram Orthopaedics position performs unexpectedly, Pacific Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacific Biosciences will offset losses from the drop in Pacific Biosciences' long position.
The idea behind Monogram Orthopaedics Common and Pacific Biosciences of pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities